Business Standard

Ahead of demerger, Piramal Pharma inducts three new board members

Piramal Enterprises has received shareholders' approval to demerge its Piramal Pharma business and simplify the corporate structure

Piramal Ent
Premium

Sohini Das Mumbai
Piramal Pharma, ahead of its demerger with Piramal Enterprises, has inducted three people into its board for assisting the company in "maintaining high governance".

Former Pfizer executive Peter Stevenson, ex-Teva executive Nathalie Leitch and corporate lawyer Sridhar Gorthi are the new board members. The de-merger is expected to be completed by this December.

“These new appointments, which come ahead of the planned demerger of PPL from Piramal Enterprises Ltd (PEL), will assist us in maintaining high governance for the new listed corporate entity,” the company said in a statement. Piramal Pharma draws only 15 percent of its revenues

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in